BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30590042)

  • 1. Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma.
    Fulciniti M; Lin CY; Samur MK; Lopez MA; Singh I; Lawlor MA; Szalat RE; Ott CJ; Avet-Loiseau H; Anderson KC; Young RA; Bradner JE; Munshi NC
    Cell Rep; 2018 Dec; 25(13):3693-3705.e6. PubMed ID: 30590042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.
    Alvarez-Benayas J; Trasanidis N; Katsarou A; Ponnusamy K; Chaidos A; May PC; Xiao X; Bua M; Atta M; Roberts IAG; Auner HW; Hatjiharissi E; Papaioannou M; Caputo VS; Sudbery IM; Karadimitris A
    Nat Commun; 2021 Sep; 12(1):5450. PubMed ID: 34521827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of tumor oncogenes by disruption of super-enhancers.
    Lovén J; Hoke HA; Lin CY; Lau A; Orlando DA; Vakoc CR; Bradner JE; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):320-34. PubMed ID: 23582323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors.
    Donato E; Croci O; Sabò A; Muller H; Morelli MJ; Pelizzola M; Campaner S
    Leukemia; 2017 Feb; 31(2):479-490. PubMed ID: 27443262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
    Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
    Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA
    Handa H; Honma K; Oda T; Kobayashi N; Kuroda Y; Kimura-Masuda K; Watanabe S; Ishihara R; Murakami Y; Masuda Y; Tahara KI; Takei H; Kasamatsu T; Saitoh T; Murakami H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription.
    Jin Z; Zhou S; Ye H; Jiang S; Yu K; Ma Y
    Biomed Pharmacother; 2019 Nov; 119():109434. PubMed ID: 31536933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes.
    Pellicelli M; Picard C; Wang D; Lavigne P; Moreau A
    PLoS One; 2016; 11(11):e0165951. PubMed ID: 27802335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
    Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
    Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
    Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
    Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression.
    Lenhart R; Kirov S; Desilva H; Cao J; Lei M; Johnston K; Peterson R; Schweizer L; Purandare A; Ross-Macdonald P; Fairchild C; Wong T; Wee S
    Mol Cancer Ther; 2015 Oct; 14(10):2167-74. PubMed ID: 26253517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
    Chapuy B; McKeown MR; Lin CY; Monti S; Roemer MG; Qi J; Rahl PB; Sun HH; Yeda KT; Doench JG; Reichert E; Kung AL; Rodig SJ; Young RA; Shipp MA; Bradner JE
    Cancer Cell; 2013 Dec; 24(6):777-90. PubMed ID: 24332044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis.
    Brown JD; Lin CY; Duan Q; Griffin G; Federation A; Paranal RM; Bair S; Newton G; Lichtman A; Kung A; Yang T; Wang H; Luscinskas FW; Croce K; Bradner JE; Plutzky J
    Mol Cell; 2014 Oct; 56(2):219-231. PubMed ID: 25263595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.
    Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL
    Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.